Toll Free: 1-888-928-9744

Rosacea Global Clinical Trials Review, H1, 2016

Published: Mar 31, 2016 | Pages: 100 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Rosacea Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Rosacea Global Clinical Trials Review, H1, 2016" provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Clinical Trials by G7 Countries: Proportion of Rosacea to Dermatology Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Rosacea to Dermatology Clinical Trials 16 Clinical Trials by Phase 17 In Progress Trials by Phase 18 Clinical Trials by Trial Status 19 Clinical Trials by End Point Status 20 Subjects Recruited Over a Period of Time 21 Clinical Trials by Sponsor Type 22 Prominent Sponsors 23 Top Companies Participating in Rosacea Therapeutics Clinical Trials 24 Prominent Drugs 26 Clinical Trial Profile Snapshots 27 Appendix 97 Abbreviations 97 Definitions 97 Research Methodology 98 Secondary Research 98 About GlobalData 99 Contact Us 99 Disclaimer 99 Source 100
List of Tables
Rosacea Therapeutics, Global, Clinical Trials by Region, 2016* 5 Rosacea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Rosacea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Rosacea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Rosacea Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Rosacea Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Rosacea Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Proportion of Rosacea to Dermatology Clinical Trials, G7 Countries (%), 2016* 13 Rosacea Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Rosacea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Rosacea to Dermatology Clinical Trials, E7 Countries (%), 2016* 16 Rosacea Therapeutics, Global, Clinical Trials by Phase, 2016* 17 Rosacea Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18 Rosacea Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Rosacea Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Rosacea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Rosacea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22 Rosacea Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Rosacea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25 Rosacea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26


List of Figures
Rosacea Therapeutics, Global, Clinical Trials by Region (%), 2016* 5 Rosacea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6 Rosacea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Rosacea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Rosacea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Rosacea Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Rosacea Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12 Proportion of Rosacea to Dermatology Clinical Trials, G7 Countries (%), 2016* 13 Rosacea Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Rosacea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Rosacea to Dermatology Clinical Trials, E7 Countries (%), 2016* 16 Rosacea Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17 Rosacea Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18 Rosacea Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19 Rosacea Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20 Rosacea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21 Rosacea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22 Rosacea Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23 Rosacea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24 Rosacea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26 GlobalData Methodology 98

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...

Global Automated Test Equipment (ATE) market is expected to be valued at USD 4.48 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing design complexity coupled with need for effective testing is expected to drive the gl

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Global thermoplastic polyurethane (TPU) films market size is likely to be valued at USD 724.6 million by 2020; as per a new research report by Radiant Insights, Inc. Increase in lightweight plastics demand in order to achieve vehicle fuel efficiency

Read More...

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify